Effect of Mobile Application Usage on Drug Compliance After Thyroidectomy
NCT ID: NCT05503576
Last Updated: 2022-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2022-12-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Mobile Application on Hypothyroid Patients
NCT05708456
Clinical Feasibility of Disease Managing Mobile App for Hyperthyroidism
NCT05828732
Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy
NCT03295955
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
NCT06853925
Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
NCT03009357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the management of complications in the postoperative period, monitoring of thyroid hormone and calcium levels is of vital importance in patients. In the case of calcium deficiency in patients, calcium replacement is performed. Levothyroxine replacement is applied to correct thyroid hormone deficiency. When the optimal dose of levothyroxine is adjusted and used appropriately, the rate of side effects is very low. Although the appropriate dose for the patients is determined in the process, thyroid hormone stabilization has the potential to deteriorate over the years.
Medication incompatibility is an important problem in thyroidectomy patients who need to receive levothyroxine replacement throughout their lives. Many studies evaluating drug compliance in the literature have been conducted with samples of internal medicine patients. However, drug compliance after thyroidectomy is an acute and important condition. There is a need for interventions to increase drug compliance in this patient group.
Today, mobile applications are becoming a new trend among technological approaches that increase the patient and nurse contact. However, no study has been found in the literature examining the use of mobile applications and drug compliance and drug level monitoring in thyroidectomy patients. In our randomized controlled study, data will be collected from two patient groups, the experimental and control groups, and the effectiveness of the reminder mobile application will be evaluated. While no additional intervention was applied to the patients in the control group; Patients in the experimental group will be provided to use the Reminder Mobile Application. At the end of the study, it is predicted that the Reminder Mobile Application will increase drug compliance and complication management of patients after thyroidectomy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
reminder mobile application group
The mobile application will be introduced with a video demonstration. Then, with the help of the researcher, the mobile application will be downloaded to his phone. A user name and password will be created for the patient to enter the application. It will be explained that medication and appointment reminders are available in the application. It will be emphasized that the application will direct you to the hospital appointment system to create a control appointment. In addition, it will be announced that the training content prepared with the contribution of experts to increase drug compliance can be accessed through the application. It is thought that the patient will be interviewed for approximately 20 minutes for the information and procedure process. In the next process, the "Drug Protocol Information Form", "Modified Morisky Scale" and "Complications Follow-up Form" sent to the patient through the application will be filled in at the 1st, 4th, 8th and 12th weeks.
reminder mobile application
After thyroidectomy, patients will be reminded of medication and control appointments. In addition, patients will be able to access up-to-date and short trainings.
standard protocol group
If the patient is in the control group in group assignment; After the first encounter and obtaining consent, the "Personal Information Form" will be filled in. Next 1., 4.,8. And in the 12th weeks, the "Drug Protocol Information Form", "Modified Morisky Scale" and "Complications Follow-up Form" will be filled in by telephone interviewing the patient. It is estimated that each phone call with the patient for data collection will take approximately 10 minutes.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
reminder mobile application
After thyroidectomy, patients will be reminded of medication and control appointments. In addition, patients will be able to access up-to-date and short trainings.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being between the ages of 18-65,
* Mental status problem,
* Psychiatric experimentation that reduces understanding and communication,
* Hearing and visual impairment,
* Being able to speak, read, read Turkish,
* Total thyroidectomy performed by the same surgeon, and
* Smart android system phone replacement.
\-
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cukurova University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pinar Kaya
PhD student
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17992086462
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.